US Codex
C.F.R.
Browse by date
Notes

§346.3. Definitions.

21 C.F.R. § 346.3

As used in this part:
(a)
Analgesic, anesthetic drug. A topically (externally) applied drug that relieves pain by depressing cutaneous sensory receptors.
(b)
Anorectal drug. A drug that is used to relieve symptoms caused by anorectal disorders in the anal canal, perianal area, and/or the lower rectal areas.
(c)
Antipruritic drug. A topically (externally) applied drug that relieves itching by depressing cutaneous sensory receptors.
(d)
Astringent drug. A drug that is applied topically (externally) to the skin or mucous membranes for a local and limited protein coagulant effect.
(e)
External use. Topical application of an anorectal drug product to the skin of the perianal area and/or the skin of the anal canal.
(f)
Intrarectal use. Topical application of an anorectal drug product to the mucous membrane of the rectum.
(g)
Keratolytic drug. A drug that causes desquamation (loosening) and debridement or sloughing of the surface cells of the epidermis.
(h)
Local anesthetic drug. A drug that produces local disappearance of pain, burning, itching, irritation, and/or discomfort by reversibly blocking nerve conduction when applied to nerve tissue in appropriate concentrations.
(i)
Protectant drug. A drug that provides a physical barrier, forming a protective coating over skin or mucous membranes.
(j)
Vasoconstrictor. A drug that causes temporary constriction of blood vessels.
Notes, amendments, and revision history

Authority

Authority: 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.

Source

Source: 55 FR 31779, Aug. 3, 1990, unless otherwise noted.